Take a look inside this month's issue of Contemporary OB/GYN.
Three months after copper intrauterine device (IUD) insertion, nearly 1/3 of women were diagnosed with vulvovaginal candidiasis, compared to nearly 25% of women who received a hormonal IUD, according to a prospective study published in the journal Cellular and Molecular Biology.
Not only for football and safety but also for productivity and efficiency.
Laparoscopy remains the gold standard for diagnosis and treatment of the disease.
Clinical pearls for assessment and management of the pregnant patient with a uterovaginal anomaly.
Although leadership in our post-pandemic climate is probably no more challenging than at any other time, it certainly feels that way.
Stay tuned for more articles as they go live!